Showing results (81-90 of 879) with videos related to

Sort By:
Pageof 88
Diabetes, Obesity & Metabolism|December 3, 2020
The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomesDaniel V O'Hara, Thomas R Parkhill, Sunil V Badve, et al.
Clinical Kidney Journal|July 5, 2021
Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) ProgramMatthew R Weir, April Slee, Tao Sun, et al.
Plos One|September 13, 2017
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysisSong Ren, Ying Wang, Li Xian, et al.
Diabetes Care|September 13, 2013
Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunctionPer-Henrik Groop, Mark E Cooper, Vlado Perkovic, et al.
JAMA|July 12, 2017
Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysisJie Yu, Zien Zhou, R Doug McEvoy, et al.
BMJ Global Health|December 5, 2019
Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic reviewBrendan Smyth, Konlawij Trongtrakul, Anna Haber, et al.
The New England Journal of Medicine|May 13, 2026
Telitacicept for IgA Nephropathy - Interim Analysis of a Phase 3 TrialJicheng Lv, Lijun Liu, Wenxiang Wang, et al.
The Cochrane Database of Systematic Reviews|April 17, 2009
HMG CoA reductase inhibitors (statins) for dialysis patientsSankar D Navaneethan, Sagar U Nigwekar, Vlado Perkovic, et al.
The Cochrane Database of Systematic Reviews|December 14, 2012
Antihypertensive agents for preventing diabetic kidney diseaseJicheng Lv, Vlado Perkovic, Celine V Foote, et al.
Kidney International Reports|October 21, 2024
Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA NephropathyJingyi Li, Jicheng Lv, Muh Goet Wong, et al.
Pageof 88